A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 10,112 shares of TKNO stock, worth $51,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,112
Holding current value
$51,672
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.29 - $2.81 $13,044 - $28,414
10,112 New
10,112 $13,000
Q1 2023

May 15, 2023

BUY
$2.74 - $6.25 $39,313 - $89,675
14,348 New
14,348 $42,000

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $143M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.